During the past decade, North Miami Research Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Miami Research Inc." #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "North Miami Research Inc." are "Opioid-Induced Bowel Dysfunction" (2 trials). Many other conditions were trialed in "North Miami Research Inc." in a lesser frequency.

Most popular intervention types in "North Miami Research Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lubiprostone" (1 trials), "Lubiprostone 24" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Miami Research Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "North Miami Research Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in North Miami Research Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Miami Research Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".